Evidence review
Dandelion for Liver
Taraxacum officinale
The short answer
Long traditional useNot as a liver treatment. EMA accepts dandelion root as a traditional bitter for mild indigestion and poor appetite, not for liver disease, and advises against medicinal doses with gallstones, bile-duct blockage, or existing liver disease. Human evidence for liver enzymes or fatty liver is almost absent for common dandelion; one small trial used a related species. Milk thistle has far more liver research. A digestive tea is reasonable; a detox cleanse is not.
6 key studies reviewed
Updated November 16, 2026
Key points
-
01
Traditional bitter, not a liver medicine
EMA accepts dandelion root for mild fullness, wind, slow digestion, and temporary loss of appetite on long use alone. It does not accept a liver-disease indication, and NCCIH finds no compelling evidence for any condition.
-
02
Human liver trials are almost absent
EMA found no clinical efficacy studies for Taraxacum officinale. One small 2026 NAFLD trial used Taraxacum peregrinum capsules, a related species, and does not overturn the traditional rating or EMA’s liver-disease caution.
-
03
Milk thistle is the stronger liver herb
Milk thistle has decades of liver trials, including a 48-week NASH study, and EMA accepts it to support liver function once serious disease is ruled out. Dandelion’s liver story is mostly tradition and animal work.
-
04
Bile, gallstones, and daisy allergy
Because bitters may stimulate bile flow, EMA advises against medicinal dandelion with gallstones, blocked or inflamed bile ducts, liver disease, or other biliary disease, and with daisy-family allergy.
-
05
Skip detox cleanses
Multi-herb “liver detox” teas have been linked to acute liver injury in case reports. A single-herb root tea for mild indigestion is a different product from an unlabeled cleanse blend.
Dandelion has a long folk reputation as a “liver herb,” but that reputation is stronger than the clinical evidence. The European Medicines Agency (EMA) accepts dandelion root, and root with herb, as traditional herbal medicines for mild digestive complaints such as fullness, wind, and slow digestion, and for temporary loss of appetite, based on long use rather than trials. It does not accept dandelion as a treatment for fatty liver, hepatitis, cirrhosis, or jaundice. NCCIH concludes that there is no compelling scientific evidence for dandelion in any health condition. Milk thistle remains the better-studied herbal option when people look for liver support.
Common dandelion (Taraxacum officinale) is a daisy-family (Asteraceae) perennial. The dried root (Taraxaci radix), the leaf (Taraxaci folium), and root with herb each have their own EMA monograph. Older European texts recommended the root for jaundice, gallstones, and even progressive cirrhosis, and the yellow flowers once invited a doctrine-of-signatures reading as a bilious plant. Modern regulators have narrowed those claims: bitters are thought to stimulate bile flow, which is also why EMA advises against medicinal dandelion in people with gallstones, a blocked bile duct, cholangitis, liver disease, or other biliary disease, the same pattern used for artichoke leaf.
This page separates traditional digestive use from liver-disease claims, reviews the scarce human data and the animal bile and liver work behind the folklore, compares dandelion with milk thistle, and covers allergy, gallbladder, and drug cautions. Nothing here is medical advice. Yellowing of the skin or eyes, dark urine, pale stools, itching without a rash, swelling of the abdomen or legs, or pain under the right ribs needs a doctor, not a stronger bitter tea.
02 The trials
Key studies
The trials and reviews that carry the most weight for this question, with the product and dose each one tested. Results apply to the preparation studied.
-
Abolhasani et al., 2026
Randomized, double-blind, placebo-controlled, single-center trial
- Who
- 50 adults with grade 2 or 3 NAFLD (25 per group), Iran
- What and how much
- GHASEDAK Taraxacum peregrinum capsules, 300 mg three times daily (900 mg/day), plus lifestyle advice
- How long
- 12 weeks
In the dandelion group, FibroScan-measured liver stiffness fell from 6.97 to 5.87, ALT from 62.5 to 41.9 U/L, and AST from 46.7 to 28.2 U/L (all p < 0.0001 within group). The authors reported benefit versus placebo, but the published abstract does not give placebo change numbers. The product used Taraxacum peregrinum, not T. officinale, and EMA advises against medicinal dandelion in people who already have liver disease.
-
Clare et al., 2009
Open pilot study; no placebo, self-recorded fluid intake and urine
- Who
- 17 healthy volunteers
- What and how much
- Fresh-leaf hydroethanolic extract of Taraxacum officinale, 8 mL three times in one day
- How long
- 1 dosing day with baseline and follow-up days
Urination frequency rose in the five hours after the first dose (p < 0.05), and the urine-to-fluid excretion ratio rose after the second (p < 0.001); the third dose changed nothing. The study was not about the liver. EMA later noted the lack of blinding, small numbers, and self-recording as limits.
-
Gavin, Caulfield, and Egan, 2026
Open-label counterbalanced crossover; no funding declared
- Who
- 14 physically active young adults (12 men, 2 women)
- What and how much
- About 2.1 g commercial dandelion root powder in four capsules with 1 L water, versus 1 L water alone
- How long
- 4 hours after each visit
Cumulative urine output was 1,268 g with dandelion and 1,164 g with water alone, a mean difference of 105 g that was not statistically significant (p = 0.13). The authors found no support for a diuretic effect of this root powder under the protocol tested.
-
Davaatseren et al., 2013 (MCD diet)
Controlled animal study in a mouse NASH model
- Who
- C57BL/6 mice fed a methionine- and choline-deficient diet
- What and how much
- Dandelion leaf extract mixed into the diet at 200 or 500 mg/kg body weight daily
- How long
- 4 weeks
Adding the leaf extract dampened histologic signs of steatohepatitis, lowered serum ALT, hepatic triglycerides and malondialdehyde, and reduced TNF-α and IL-6 expression compared with the MCD diet alone. This is animal evidence only and does not show benefit in people with fatty liver.
-
Davaatseren et al., 2013 (high-fat diet)
Controlled animal study of diet-induced fatty liver
- Who
- C57BL/6 mice on normal chow or high-fat diet
- What and how much
- High-fat diet supplemented with dandelion leaf extract at 2 or 5 g/kg diet
- How long
- Diet-feeding period as reported in the paper
Leaf-extract supplementation reduced hepatic fat accumulation, body and liver weight, serum triglycerides, cholesterol, insulin, and fasting glucose versus high-fat diet alone, with greater AMPK activation in liver and muscle. Again animal-only; doses relative to human tea use were high.
-
Herrera Vielma et al., 2025
Narrative review of preclinical hepatoprotective studies
- Who
- Published animal and laboratory studies of Taraxacum officinale
- What and how much
- Various dandelion extracts and isolated taraxasterol
- How long
- Literature reviewed through the authors’ search window
The reviewers concluded that animal studies suggest protection against alcohol-, carbon tetrachloride–, and paracetamol-related liver injury, but that clinical trials are still needed to confirm safety and efficacy in human liver disease. They did not identify an established human dosing regimen for liver treatment.
03 Evidence
What the research shows
Our rating for Dandelion for Liver, based on the studies below.
For the species regulators assess, Taraxacum officinale, EMA’s assessment reports found no clinical efficacy studies. The 2021 root monograph and the 2009 leaf and root-with-herb monographs are traditional-use listings only. Digestion and appetite are the accepted European indications for the root; increasing urine to flush the urinary tract is the other traditional indication for root and leaf. Neither indication is a license to treat liver disease. A 2025 narrative review in Pharmaceuticals likewise concluded that hepatoprotective findings are preclinical and that human trials are still needed. NCCIH’s consumer summary is blunt: there is no compelling scientific evidence for any health condition.
The one recent human fatty-liver trial is easy to overread. Abolhasani and colleagues (Current Drug Therapy 2026) randomized 50 adults with ultrasound grade 2 or 3 nonalcoholic fatty liver disease (NAFLD) at a single Iranian center to 900 mg a day of GHASEDAK dandelion capsules or placebo for 12 weeks, alongside lifestyle advice. In the active group, FibroScan liver-stiffness readings and the liver enzymes ALT and AST fell, and the authors reported benefit compared with placebo. The abstract does not publish the placebo change figures, the trial is small and single-center, and the labeled plant was Taraxacum peregrinum, a related species, not the T. officinale of EMA’s monographs. It cannot carry a general claim that common dandelion treats NAFLD, and it sits awkwardly beside EMA’s advice that people who already have liver disease should avoid medicinal dandelion.
Everything else behind the liver story is older pharmacology and animals. EMA summarizes classic bile experiments: a water decoction of leaves raised hourly bile volume by up to 40% in rats (Böhm 1959), and an intravenous decoction doubled bile flow over 30 minutes in dogs (Chabrol 1931). Those findings support the bitter-and-bile tradition and the gallbladder cautions; they are not human outcome data. In mice, Davaatseren and colleagues (Journal of Medicinal Food 2013; Food and Chemical Toxicology 2013) reported that leaf extract eased methionine- and choline-deficient and high-fat diet liver injury, with lower ALT, less hepatic fat, and anti-inflammatory signals. Laboratory and animal work also includes carbon tetrachloride and alcohol models summarized by EMA and MSKCC. None of this shows that a cup of root tea improves liver function tests, scarring, or survival in people.
Milk thistle (Silybum marianum) is the honest comparison. It has far more clinical research for liver disease, including a 48-week randomized trial in 99 people with nonalcoholic steatohepatitis (NASH) in which fibrosis improved in more people on silymarin than on placebo, even though the trial missed its primary end point, and a Cochrane review that found no clear effect on deaths or complications in alcohol-related and viral liver disease. EMA accepts specified milk thistle preparations as a traditional remedy to support liver function after a doctor has ruled out serious disease. Our liver guide ranks milk thistle first and dandelion as traditional only. Artichoke leaf, often sold for fatty liver and cholesterol, shares dandelion’s bile-flow caution: EMA contraindicates it in liver disease, gallstones, and bile-duct obstruction, and a small 2026 pilot even saw liver enzymes rise while liver fat fell.
Human studies that people sometimes quote for dandelion are about urine, not the liver. Clare and colleagues (Journal of Alternative and Complementary Medicine 2009) saw more frequent urination after a fresh-leaf extract in 17 volunteers on a single day. Gavin, Caulfield, and Egan (International Journal of Sport Nutrition and Exercise Metabolism 2026) found no significant extra urine when 14 young adults took about 2.1 g of root powder with a liter of water. Those results matter for the diuretic tradition; they do not fill the gap in liver trials. Combination “liver” products that mix dandelion with milk thistle, turmeric, or other herbs also cannot credit any one ingredient, and multi-herb detox teas are the products behind published injury reports.
04 In practice
How it was taken in studies
If you want dandelion for its traditional digestive role rather than as a liver drug, match the product to EMA’s root monograph. Typical adult and adolescent options include a decoction of 1 to 5 g of cut root in 150 ml of water two or three times a day; fresh root juice 4 to 8 ml three times a day; a 1:1 liquid extract in 30% alcohol, 2 to 8 ml three times a day; or a 1:5 tincture in 45% alcohol, 5 to 10 ml three times a day. For temporary loss of appetite, take the preparation about half an hour before meals. Root-with-herb and leaf products have their own dose ranges and are listed mainly for urinary flushing or, for root with herb, the same mild digestive complaints. Check the label for plant part: “dandelion” alone can mean leaf, root, or both.
Courses are meant to be short. EMA advises seeing a doctor if digestive or urinary symptoms last more than two weeks while taking a dandelion medicine. None of the monographs recommend medicinal dandelion under age 12, in pregnancy, or while breastfeeding, because safety has not been established. Food use is a different exposure: young leaves as a bitter salad green and roasted root as a caffeine-free coffee substitute are traditional foods, not concentrated liver extracts. Gather wild plants only from clean ground, away from roads and sprayed lawns, because surveys cited by EMA found lead and other metals in some wild dandelions.
Do not use medicinal dandelion to treat diagnosed liver disease, to “cleanse” the liver, or to replace weight loss, alcohol reduction, hepatitis care, or prescribed medicines. If you and a clinician decide a traditional bitter is reasonable for mild indigestion, choose a single-herb product that names Taraxacum officinale and the plant part, keep the course short, and stop for yellowing skin or eyes, dark urine, pale stools, fever, painful urination, or new right-upper-abdominal pain. Avoid stacking several bitter or detox teas at once, and skip unlabeled multi-ingredient liver cleanses.
05 Caution
Before you try dandelion
Stomach upset is the usual complaint at medicinal doses: MSKCC lists heartburn, stomach ache, and mild diarrhea at high doses. Allergy is the main specific risk. EMA contraindicates dandelion in people hypersensitive to it or to other Asteraceae plants such as ragweed, chrysanthemums, marigolds, and daisies. The latex contains sesquiterpene lactones such as taraxinic acid glucoside, a known contact sensitizer, and contact dermatitis from handling the plant is well described. NCCIH notes conflicting evidence on cross-reaction with related plants and possible reactions to topical dandelion in people with eczema. Anaphylaxis is possible though uncommon.
Gallbladder and liver cautions mirror those for artichoke. EMA’s leaf and root-with-herb monographs contraindicate use with bile-duct obstruction, cholangitis, liver disease, gallstones, active peptic ulcer, and other biliary disease. The 2021 root monograph keeps the same list as a warning that root is not recommended because of possible bile stimulation, moved from contraindications only for lack of supporting pharmacovigilance data, not because the concern was dismissed. People with kidney failure, diabetes, or heart failure should be cautious with leaf and root-with-herb products because of potassium content. A multi-herb liver detox tea containing dandelion root, burdock, nettle, and other ingredients was linked to cholestatic acute liver injury in a 36-year-old woman (Niazi and colleagues, Case Reports in Gastroenterology 2022); she improved after stopping. Causality cannot be pinned on dandelion alone, but it is a reason to avoid detox blends.
EMA’s monographs list no documented drug interactions, yet assessment reports and clinical summaries flag theoretical ones: lithium toxicity if a diuretic herb causes dehydration; additive effects with prescription diuretics; higher potassium risk with ACE inhibitors, potassium-sparing diuretics, and related drugs; possible additive blood-sugar lowering with diabetes medicines; and, from animal and test-tube work, effects on CYP1A2, CYP3A4, and UGT enzymes. MSKCC cites toxic levels of anti-rejection drugs in a transplant recipient who drank a herbal tea containing dandelion. Warfarin users should keep vitamin K intake steady if they eat the greens. Ask a pharmacist before combining medicinal dandelion with lithium, water pills, diabetes drugs, blood thinners, or transplant medicines.
Jaundice and other liver red flags need medical care, not bitters. See a doctor promptly for yellow skin or eyes, dark urine, pale or clay-colored stools, itching without a rash, pain or swelling under the right ribs, swelling of the abdomen or legs, easy bruising, confusion, or vomiting blood. NIDDK lists these among signs that cirrhosis or other serious liver disease may already be advanced. Suspected gallbladder attack with severe right-upper pain, fever, or vomiting likewise needs urgent assessment. Do not start a bitter tea to treat those symptoms.
06 Questions
Frequently Asked Questions
No human study shows that it does. The liver reputation comes from tradition, animal bile-flow experiments, and laboratory work. EMA accepts dandelion root for mild indigestion and poor appetite, not as a liver cleanse, and advises against medicinal doses in people who already have liver disease. A multi-herb detox tea containing dandelion has been linked to acute liver injury. Our guide to herbs for liver health explains what actually protects the liver.
No. Milk thistle has far more clinical research, including trials in fatty liver inflammation and alcohol-related and viral liver disease, and EMA accepts it to support liver function once a doctor has ruled out serious disease. Dandelion’s evidence for liver disease is traditional and preclinical. If you are comparing options, start with milk thistle’s monograph and our liver herbs guide, and involve your clinician if you have abnormal liver tests.
Not as self-treatment. EMA advises against medicinal dandelion with existing liver disease, and bitters that may increase bile flow are a poor match for unexplained jaundice or known biliary disease. Lifestyle change, alcohol reduction, and prescribed care matter far more than any tea. Discuss every herb with your liver specialist before using it.
Older European herbals listed jaundice, gallstones, and even cirrhosis among folk uses, and animal studies of bile flow and toxin protection keep the story alive. Modern EU monographs narrowed the claim to mild digestive complaints and urinary flushing on traditional grounds. Supplement marketing often lags behind that regulatory cut.
Both are bitter daisy-family plants traditionally linked to bile flow, and EMA uses a similar caution list: avoid medicinal use with gallstones, bile-duct obstruction, or liver disease. Artichoke leaf has human data for indigestion and mixed cholesterol trials (see artichoke for cholesterol), while dandelion’s human liver data remain thinner. Neither replaces medical care for gallbladder or liver disease.
Roasted root coffee is a caffeine-free food drink, not a proven liver therapy. It still carries daisy-family allergy and biliary cautions if you drink it in medicinal amounts. For mild sluggish digestion, a traditional bitter before meals is the use EMA recognizes; for liver disease, see a doctor and consider better-studied options such as milk thistle only with clinical advice.
Get medical care for yellow skin or eyes, dark urine, pale stools, itching without a rash, swelling of the abdomen or legs, confusion, vomiting blood, or severe pain under the right ribs. EMA also says to see a doctor if mild digestive symptoms last more than two weeks on a dandelion product. Those signs can mean hepatitis, bile-duct blockage, or advanced liver disease, which a bitter tea cannot treat.
07 References
Sources
These references support the claims on this page. They are not an endorsement of any product. The dandelion monograph carries its own full source list.
-
European Union herbal monograph on Taraxacum officinale F.H. Wigg., radix
European Medicines Agency (EMA/HMPC/475726/2020), 2021
Traditional use for mild digestive disorders, temporary loss of appetite, and urinary flushing; Asteraceae allergy contraindication; not recommended with bile-duct obstruction, cholangitis, liver disease, gallstones, or other biliary disease; doses and under-12 and pregnancy warnings.
-
Assessment report on Taraxacum officinale F.H. Wigg., radix
European Medicines Agency (EMA/HMPC/475725/2020), 2021
No clinical efficacy studies found; historical liver and jaundice uses; animal bile-flow citations (Böhm, Chabrol); rationale for biliary warnings; move of gallstones from contraindications to warnings for lack of data.
-
Community herbal monograph on Taraxacum officinale Weber ex Wigg., folium
European Medicines Agency (EMA/HMPC/579636/2008), 2009
Traditional urinary flushing only; contraindications for Asteraceae allergy, bile-duct obstruction, cholangitis, liver disease, gallstones, active peptic ulcer, and other biliary disease; potassium caution in kidney failure, diabetes, and heart failure.
-
Community herbal monograph on Taraxacum officinale Weber ex Wigg., radix cum herba
European Medicines Agency (EMA/HMPC/212895/2008 Corr. 1), 2009
Traditional mild digestive and urinary indications; same biliary and ulcer contraindications as the leaf; potassium caution.
-
Dandelion: Usefulness and Safety
National Center for Complementary and Integrative Health (NIH), 2024
No compelling scientific evidence for any health condition; food amounts likely safe; theoretical interactions with antidiabetes, anticoagulant, antiplatelet, and diuretic drugs; daisy-family allergy notes.
-
Dandelion
Memorial Sloan Kettering Cancer Center, About Herbs, 2025
Traditional uses; preclinical liver and diuretic data; side effects; case reports including detox-tea liver injury, transplant-drug toxicity, and contact dermatitis; interaction cautions.
-
The Investigation of the Effect of a Dandelion Herbal Capsule (GHASEDAK Capsule) on Fibrosis and Liver Function in NAFLD
Current Drug Therapy (DOI 10.2174/0115748855419340251113172731), 2026
Abolhasani et al.: 50 adults with grade 2–3 NAFLD; Taraxacum peregrinum 900 mg/day for 12 weeks; within-group falls in FibroScan stiffness, ALT, and AST; authors reported benefit versus placebo.
-
The diuretic effect in human subjects of an extract of Taraxacum officinale folium over a single day
Journal of Alternative and Complementary Medicine (PubMed 19678785), 2009
Clare et al.: 17 volunteers; fresh-leaf extract 8 mL three times in one day; more frequent urination after first dose and higher excretion ratio after second.
-
Co-Ingestion of a Commercially Available Dandelion Root Powder Elicited No Additional Diuretic Effect Over 4 Hr Compared to Ingestion of Water Alone in Physically Active Young Adults
International Journal of Sport Nutrition and Exercise Metabolism (DOI 10.1123/ijsnem.2026-0001), 2026
Gavin, Caulfield, and Egan: 14 adults; ~2.1 g root powder with 1 L water versus water alone; urine 1,268 vs 1,164 g over 4 hours (p = 0.13).
-
Dandelion Leaf Extract Protects Against Liver Injury Induced by Methionine- and Choline-Deficient Diet in Mice
Journal of Medicinal Food (PubMed 23256442), 2013
Davaatseren et al.: mouse NASH model; leaf extract reduced histologic injury, ALT, hepatic triglycerides, and inflammatory markers.
-
Taraxacum official (dandelion) leaf extract alleviates high-fat diet-induced nonalcoholic fatty liver
Food and Chemical Toxicology (PubMed 23603008), 2013
Davaatseren et al.: high-fat-fed mice; leaf extract reduced hepatic steatosis and improved metabolic markers via AMPK.
-
The Role of Dandelion (Taraxacum officinale) in Liver Health and Hepatoprotective Properties
Pharmaceuticals (PubMed 40732279), 2025
Narrative review concluding that hepatoprotective evidence is preclinical and that clinical trials are still needed.
-
Drug-Induced Liver Injury from Herbal Liver Detoxification Tea
Case Reports in Gastroenterology (PubMed 36636365), 2022
Niazi et al.: 36-year-old woman with cholestatic acute liver injury after a multi-herb detox tea containing dandelion root; improved after stopping.
-
Symptoms & Causes of Cirrhosis
National Institute of Diabetes and Digestive and Kidney Diseases (NIH), 2023
Jaundice, dark urine, itching, right-upper abdominal discomfort, edema, ascites, easy bruising, and confusion as warning signs of advanced liver disease.
-
A Randomized Trial of Silymarin for the Treatment of Nonalcoholic Steatohepatitis
Clinical Gastroenterology and Hepatology (PubMed 28419855), 2017
Wah Kheong et al.: 99-person, 48-week NASH trial used to position milk thistle as the better-studied liver herb; fibrosis improved in more people on silymarin than placebo though the primary end point was missed.
-
European Union herbal monograph on Cynara cardunculus L. (syn. Cynara scolymus L.), folium
European Medicines Agency (EMA/HMPC/194014/2017), 2018
Artichoke leaf contraindications for Asteraceae allergy, bile-duct obstruction, cholangitis, gallstones, and liver disease, cited for the parallel bitter/bile caution pattern.